Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICCA Global is a commercial-stage integrative oncology provider that markets personalized cancer treatment programs for primary, metastatic, and recurrent solid tumors. The company operates through affiliates in Southern California and a treatment center in Tijuana, Baja California, Mexico, and emphasizes therapies that it says are often unavailable to patients in the United States and Canada. Its flagship branded approach, FivePOINTS Cancer Care, combines whole-body diagnostics, live-cell tumor profiling, tumor-targeted chemo-immunotherapy, short-course radiation, ablation, and regenerative/restorative medicine. ICCA Global appears to function primarily as a care delivery organization rather than a drug-development biotech, with services centered on individualized treatment planning and outpatient cancer care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICCA Global.